Login / Signup

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study).

Sung-Yong ChoSeong Jin JeongSangchul LeeJang Hwan KimSeong Ho LeeMin Soo ChooSeung June Oh
Published in: Neurourology and urodynamics (2021)
Mirabegron was effective in treating OAB symptoms in patients with Parkinsonism with acceptable adverse events.
Keyphrases
  • double blind
  • open label
  • sleep quality
  • clinical trial
  • parkinson disease
  • randomized controlled trial
  • study protocol
  • phase ii
  • depressive symptoms